The Investor Relations website contains information about Atea Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial ...
Atea Pharmaceuticals is a leader in the discovery of oral direct-acting antiviral therapies, including our most advanced drug candidate, ...
AVIR on Nasdaq. This company's Exchange Act ... February 28, 2024 - 10-K: Annual report for year ending December 31, 2023 ... Before you Invest, Investor.gov. Get ...
What is an IR Tech? ... AVIR is an ARRT Recognized Continuing Education Evaluation Mechanism (RCEEM). ... Job Type: Full-Time Position Overview: Oversee dai... Dual ...
Missing: investor relations
Find annual and quearterly earnings data for Atea Pharmaceuticals, Inc. Common Stock (AVIR) including earnings per share, earnings forecasts at Nasdaq.com.
Feb 29, 2024 · You can access the press release as well as the slides that we'll be reviewing today by going to the Investors section of our website at ir.
This information can be used by investors to verify and understand the financial position of the company. Many, but not all SEC filings are available in the ...
Atea Pharmaceuticals Inc. balance sheet, income statement, cash flow, earnings & estimates, ratio and margins. View AVIR financial statements in full.